ArticleNPJ digital medicine2026
AI for predicting exacerbations in KIDs with asthma (AIRE-KIDS).
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Recurrent acute care visits are a common yet preventable outcome for many children with asthma. Machine learning (ML) applied to electronic medical records (EMR) may help identify children at high risk and enable targeted referral to preventative care. We developed ML models to predict repeat asthma-related emergency department (ED) visits or hospital admissions within one year among children with a prior asthma ED visit at a tertiary children's hospital. Retrospective pre-COVID-19 data (Feb 2017-Feb 2019, N = 2716) from the Children's Hospital of Eastern Ontario (CHEO) were linked with environmental pollutant exposure and neighborhood marginalization data to train models. We evaluated boosted tree methods (LGBM, XGBoost) and three open-source large language models (DistilGPT2, Llama 3.2 1B, Llama-8b-UltraMedical). Models were tuned, calibrated, and validated using a post-COVID-19 dataset (Jul 2022-Apr 2023, N = 1237). Performance was assessed using AUC and F1 scores, with SHAP values identifying key predictors. LGBM performed best (AUC 0.712, F1 0.51), outperforming the current best practice (F1 0.334). Key predictors included prior asthma ED visits, triage acuity, medical complexity, food allergy, prior non-asthma respiratory ED visits, and age. AIRE-KIDS models accurately predict future acute care use and could support ED-based decision-making to improve equitable access to preventative asthma care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.